Trials / Completed
CompletedNCT02307370
Atherectomy By Laser Ablation With Turbo-Elite
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Spectranetics Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective for this study is to prove the safety and effectiveness of the Spectranetics Turbo-Elite catheter in atherectomy treatment for infrainguinal arteries with catheter to vessel sizing of at least 50%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Turbo-Elite Laser Catheter | Application of laser energy to remove blockage |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-11-01
- Completion
- 2016-11-01
- First posted
- 2014-12-04
- Last updated
- 2021-08-27
- Results posted
- 2021-08-27
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02307370. Inclusion in this directory is not an endorsement.